#POLB Poolbeg Pharma – SIGNIFICANT MILESTONE FOR POOLBEG’S IP PORTFOLIO March 31, 2026 – Posted in: Poolbeg Pharma (POLB)

Grant of first POLB 001 cancer immunotherapy-induced CRS patent   Significant milestone for Poolbeg’s global intellectual property portfolio   31 March 2026 – Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces that it has received formal notification of the grant for its POLB 001 cancer immunotherapy-induced Cytokine Release Syndrome (“CRS”) patent application from IP Australia, the Australian patent office.   This represents the…

Continue reading

Electric Guitar #ELEG – Update on proposed acquisition of Dunbar Energy Inc. March 30, 2026 – Posted in: Blog, Electric Guitar Plc (ELEG)

Further to the Company’s announcement of 23 December 2025, the Board of Electric Guitar PLC (LSE: ELEG) (the “Board”) provides an update on its proposed acquisition of Dunbar Energy Inc. (“Dunbar”). The Board is continuing discussions regarding the Dunbar acquisition, although this has been delayed by the changing nature of Dunbar’s asset base and structuring matters as Dunbar continues to develop its strategy in the USA of behind-the-meter (BTM) power from gas wells to local…

Continue reading

European Green Transition #EGT – Result of General Meeting – Posted in: Blog, European Green Transition Plc (EGT)

30 March 2026 – European Green Transition plc (AIM: EGT), a company focused on acquiring, integrating and optimising revenue-generating and profitable services businesses in the critical infrastructure sector, announces that, further to its circular published on 13 March 2026 (“Circular”), at the General Meeting of the Company held today, all resolutions set out in the Circular were duly passed. The voting results of the Meetings will be published on the Company’s website shortly. Accordingly, the…

Continue reading

#EGT European Green Transition PLC – UK proposals to increase onshore wind capacity March 23, 2026 – Posted in: European Green Transition Plc (EGT)

European Green Transition plc (AIM: EGT), a company focused on acquiring, integrating and optimising revenue-generating and profitable services businesses in the critical infrastructure sector, notes the UK Government’s announcement on 18 March 2026 outlining proposals to enable farmers, schools and industrial users to install small onshore wind turbines without the need for planning permission. The proposals are designed to reduce barriers to access distributed wind energy, allowing organisations to lower energy costs and accelerate the…

Continue reading

#EGT European Green Transition PLC – Investor Presentation via Investor Meet Company March 16, 2026 – Posted in: European Green Transition Plc (EGT)

European Green Transition plc (AIM: EGT), a company focused on acquiring, integrating and optimising revenue-generating and profitable services businesses in the critical infrastructure sector, announces that Cathal Friel, Executive Chair, Jack Kelly, Chief Financial Officer, and David Broadbank, Managing Director of the O&M Business will provide a live presentation via Investor Meet Company on 18 March 2026, 17:00 GMT. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via…

Continue reading

#EGT European Green Transition PLC – Notice of General Meeting & Posting of Circular March 13, 2026 – Posted in: European Green Transition Plc (EGT)

European Green Transition plc (AIM: EGT), a company focused on acquiring, integrating and optimising revenue-generating and profitable services businesses in the critical infrastructure sector, announces that, further to its announcement on 12 March 2026, a Circular containing further details of the Placing, the Subscription and the Notice of General Meeting will be posted to Shareholders today. The Circular will also be available on the Company’s website at www.europeangreentransition.com. The General Meeting will take place at the offices of DAC…

Continue reading

#POLB Poolbeg Pharma PLC – Appointment of Dr Adrian Kilcoyne to SAB March 12, 2026 – Posted in: Poolbeg Pharma (POLB)

Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the appointment of Dr Adrian Kilcoyne to its Scientific Advisory Board.   Dr Kilcoyne brings over 20 years of clinical expertise with strategic drug development leadership, focusing on innovative therapies that address unmet medical needs in oncology and immunology and, in particular, brings deep knowledge of haematological malignancies, T-cell therapies and Cytokine Release Syndrome…

Continue reading

#EGT European Green Transition PLC – Result of fundraise via placing and subscription – Posted in: European Green Transition Plc (EGT)

European Green Transition plc (AIM: EGT), a company focused on acquiring, integrating and optimising revenue-generating and profitable services businesses in the critical infrastructure sector, announces that, further to its announcement made yesterday (the “Launch Announcement”) regarding the launch of the proposed placing and subscription (the “Fundraise”), the Company has conditionally raised gross proceeds of £7.5 million in aggregate, via the placing of 64,778,653 new Ordinary Shares of 0.25 pence each (“Ordinary Shares”) by way of…

Continue reading